Addiction treatment is not the same for everyone. What works for one person may not work for another. That’s where genetic ...

Rutgers‑led study of 2.2 million people finds addiction risk is driven more by genes tied to impulse control and reward ...

Researchers analyze 2.2 million genomes to show that addiction risk is primarily driven by broad genes affecting brain wiring ...

James Kimmel, Jr., is a lecturer of psychiatry at the Yale School of Medicine, a lawyer, and the founder and co-director of the Yale Collaborative for Motive Control Studies. He is the creator of The ...

A drug called buprenorphine may be the best tool doctors have to fight the fentanyl crisis. Why hasn’t it been more widely adopted? A dose of buprenorphine, an opioid that can help treat addiction to ...

India, March 29 -- A large share of the inherited risk for substance use disorders may stem from genes that influence broader ...

A popular class of drugs for treating diabetes and obesity may reduce addiction, including abuse of alcohol, tobacco, cannabis, opioids and cocaine, according to research published March 4 by ...

The popular class of weight loss drugs known as GLP-1s have shown to be effective in curbing cravings beyond food. A few early studies have suggested that GLP-1 medications can do a lot to alleviate ...

Remarkable scientific progress over the past five decades has helped us develop knowledge of how drugs of abuse induce pleasure, reinforce use, and lead to the compulsive self-administration we call ...

A House Energy and Commerce subcommittee hearing highlighted the emerging conflict between drug policies and scientific ...